Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2021

View Archived Issues

RTX-N109D, a rituximab variant with lower sensitivity to CA125 mediated immunosuppression

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

EIDD-2749 shows broad antiviral activity against RSV, SARS-CoV-2 and related RNA viruses

ED to AD: Viagra associated with lower risk of Alzheimer's disease

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

New ACSS2 inhibitors discovered at Metabomed

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Incyte describes new mutant GTPase KRAS inhibitors

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Spago completes regulatory preclinical program with Tumorad

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Bsense reports preclinical data on BSEN-627 in rat pain model

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...